159 related articles for article (PubMed ID: 32063037)
1. Regulatory-grade clinical trial design using real-world data.
Levenson MS
Clin Trials; 2020 Aug; 17(4):377-382. PubMed ID: 32063037
[TBL] [Abstract][Full Text] [Related]
2. Examining the Use of Real-World Evidence in the Regulatory Process.
Beaulieu-Jones BK; Finlayson SG; Yuan W; Altman RB; Kohane IS; Prasad V; Yu KH
Clin Pharmacol Ther; 2020 Apr; 107(4):843-852. PubMed ID: 31562770
[TBL] [Abstract][Full Text] [Related]
3. Considerations in characterizing real-world data relevance and quality for regulatory purposes: A commentary.
Girman CJ; Ritchey ME; Zhou W; Dreyer NA
Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):439-442. PubMed ID: 30515910
[No Abstract] [Full Text] [Related]
4. Hybrid clinical trials to generate real-world evidence: design considerations from a sponsor's perspective.
Zhu M; Sridhar S; Hollingsworth R; Chit A; Kimball T; Murmello K; Greenberg M; Gurunathan S; Chen J
Contemp Clin Trials; 2020 Jul; 94():105856. PubMed ID: 31669449
[TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
6. Real-World Evidence - What Is It and What Can It Tell Us?
Sherman RE; Anderson SA; Dal Pan GJ; Gray GW; Gross T; Hunter NL; LaVange L; Marinac-Dabic D; Marks PW; Robb MA; Shuren J; Temple R; Woodcock J; Yue LQ; Califf RM
N Engl J Med; 2016 Dec; 375(23):2293-2297. PubMed ID: 27959688
[No Abstract] [Full Text] [Related]
7. [Real-world evidence.].
De Fiore L; Addis A
Recenti Prog Med; 2017 Dec; 108(12):497-499. PubMed ID: 29297897
[TBL] [Abstract][Full Text] [Related]
8. Use of Real-World Evidence to Support FDA Approval of Oncology Drugs.
Feinberg BA; Gajra A; Zettler ME; Phillips TD; Phillips EG; Kish JK
Value Health; 2020 Oct; 23(10):1358-1365. PubMed ID: 33032780
[TBL] [Abstract][Full Text] [Related]
9. Trial designs using real-world data: The changing landscape of the regulatory approval process.
Baumfeld Andre E; Reynolds R; Caubel P; Azoulay L; Dreyer NA
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1201-1212. PubMed ID: 31823482
[TBL] [Abstract][Full Text] [Related]
10. Five analytic challenges in working with electronic health records data to support clinical trials with some solutions.
Goldstein BA
Clin Trials; 2020 Aug; 17(4):370-376. PubMed ID: 32589046
[TBL] [Abstract][Full Text] [Related]
11. Series: Pragmatic trials and real world evidence: Paper 8. Data collection and management.
Meinecke AK; Welsing P; Kafatos G; Burke D; Trelle S; Kubin M; Nachbaur G; Egger M; Zuidgeest M;
J Clin Epidemiol; 2017 Nov; 91():13-22. PubMed ID: 28716504
[TBL] [Abstract][Full Text] [Related]
12. Regulatory and scientific issues regarding use of foreign data in support of new drug applications in the United States: an FDA perspective.
Khin NA; Yang P; Hung HM; Maung-U K; Chen YF; Meeker-O'Connell A; Okwesili P; Yasuda SU; Ball LK; Huang SM; O'Neill RT; Temple R
Clin Pharmacol Ther; 2013 Aug; 94(2):230-42. PubMed ID: 23588316
[TBL] [Abstract][Full Text] [Related]
13. Exploring the ethical and regulatory issues in pragmatic clinical trials.
Califf RM; Sugarman J
Clin Trials; 2015 Oct; 12(5):436-41. PubMed ID: 26374676
[TBL] [Abstract][Full Text] [Related]
14. The US Food and Drug Administration's expedited approval programs: Evidentiary standards, regulatory trade-offs, and potential improvements.
Wallach JD; Ross JS; Naci H
Clin Trials; 2018 Jun; 15(3):219-229. PubMed ID: 29871509
[TBL] [Abstract][Full Text] [Related]
15. Adaptive trial design: its growing role in clinical research and implications for pharmacists.
Cirulli J; McMillian WD; Saba M; Stenehjem D
Am J Health Syst Pharm; 2011 May; 68(9):807-13. PubMed ID: 21515864
[TBL] [Abstract][Full Text] [Related]
16. Innovative design and analysis for rare disease drug development.
Chow SC; Huang Z
J Biopharm Stat; 2020 May; 30(3):537-549. PubMed ID: 32065047
[TBL] [Abstract][Full Text] [Related]
17. Harnessing electronic healthcare data for wound care research: Standards for reporting observational registry data obtained directly from electronic health records.
Fife CE; Eckert KA
Wound Repair Regen; 2017 Apr; 25(2):192-209. PubMed ID: 28370796
[TBL] [Abstract][Full Text] [Related]
18. Real-world Data for Clinical Evidence Generation in Oncology.
Khozin S; Blumenthal GM; Pazdur R
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059439
[TBL] [Abstract][Full Text] [Related]
19. Contemporary use of real-world data for clinical trial conduct in the United States: a scoping review.
Rogers JR; Lee J; Zhou Z; Cheung YK; Hripcsak G; Weng C
J Am Med Inform Assoc; 2021 Jan; 28(1):144-154. PubMed ID: 33164065
[TBL] [Abstract][Full Text] [Related]
20. Pragmatic clinical trials in the context of regulation of medicines.
Gedeborg R; Cline C; Zethelius B; Salmonson T
Ups J Med Sci; 2019 Jan; 124(1):37-41. PubMed ID: 30251577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
